Tissue transglutaminase in tumour progression

Friend or foe?

P. Kotsakis, Martin Griffin

Research output: Contribution to journalArticle

Abstract

Basic biological processes in which tissue transglutaminase (TG2, tTG) is thought to be important including apoptosis, cell adhesion and migration, ECM homeostasis and angiogenesis are key stages in the multistage tumour progression cascade. Studies undertaken with primary tumours and experimental models suggest that TG2 expression and activity in the tumour body and surrounding matrix generally decreases with tumour progression, favouring matrix destabilisation, but supporting angiogenesis and tumour invasion. In contrast, in the secondary metastatic tumour TG2 is often highly expressed whereby its potential roles in cell survival both at the intra- and extracellular level become important. In the following review the underlying molecular basis for the selection of these different phenotypes in tumour types and the anomaly for the requirement of TG2 is discussed in relation to the complex events of tumour progression. © 2007 Springer-Verlag.

Original languageEnglish
Pages (from-to)373-384
Number of pages12
JournalAmino Acids
Volume33
Issue number2
DOIs
Publication statusPublished - Aug 2007

Fingerprint

Tumors
Neoplasms
Military electronic countermeasures
Biological Phenomena
transglutaminase 2
Cell adhesion
Cell Adhesion
Cell Movement
Cell Survival
Homeostasis
Theoretical Models
Cells
Apoptosis
Phenotype

Keywords

  • angiogenesis
  • enzyme
  • extracellular matrix
  • tissue transglutaminase
  • tumour growth

Cite this

@article{debb3dca628d46178efbaefd0b397590,
title = "Tissue transglutaminase in tumour progression: Friend or foe?",
abstract = "Basic biological processes in which tissue transglutaminase (TG2, tTG) is thought to be important including apoptosis, cell adhesion and migration, ECM homeostasis and angiogenesis are key stages in the multistage tumour progression cascade. Studies undertaken with primary tumours and experimental models suggest that TG2 expression and activity in the tumour body and surrounding matrix generally decreases with tumour progression, favouring matrix destabilisation, but supporting angiogenesis and tumour invasion. In contrast, in the secondary metastatic tumour TG2 is often highly expressed whereby its potential roles in cell survival both at the intra- and extracellular level become important. In the following review the underlying molecular basis for the selection of these different phenotypes in tumour types and the anomaly for the requirement of TG2 is discussed in relation to the complex events of tumour progression. {\circledC} 2007 Springer-Verlag.",
keywords = "angiogenesis, enzyme, extracellular matrix, tissue transglutaminase, tumour growth",
author = "P. Kotsakis and Martin Griffin",
year = "2007",
month = "8",
doi = "10.1007/s00726-007-0516-1",
language = "English",
volume = "33",
pages = "373--384",
journal = "Amino Acids",
issn = "0939-4451",
publisher = "Springer",
number = "2",

}

Tissue transglutaminase in tumour progression : Friend or foe? / Kotsakis, P.; Griffin, Martin.

In: Amino Acids, Vol. 33, No. 2, 08.2007, p. 373-384.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Tissue transglutaminase in tumour progression

T2 - Friend or foe?

AU - Kotsakis, P.

AU - Griffin, Martin

PY - 2007/8

Y1 - 2007/8

N2 - Basic biological processes in which tissue transglutaminase (TG2, tTG) is thought to be important including apoptosis, cell adhesion and migration, ECM homeostasis and angiogenesis are key stages in the multistage tumour progression cascade. Studies undertaken with primary tumours and experimental models suggest that TG2 expression and activity in the tumour body and surrounding matrix generally decreases with tumour progression, favouring matrix destabilisation, but supporting angiogenesis and tumour invasion. In contrast, in the secondary metastatic tumour TG2 is often highly expressed whereby its potential roles in cell survival both at the intra- and extracellular level become important. In the following review the underlying molecular basis for the selection of these different phenotypes in tumour types and the anomaly for the requirement of TG2 is discussed in relation to the complex events of tumour progression. © 2007 Springer-Verlag.

AB - Basic biological processes in which tissue transglutaminase (TG2, tTG) is thought to be important including apoptosis, cell adhesion and migration, ECM homeostasis and angiogenesis are key stages in the multistage tumour progression cascade. Studies undertaken with primary tumours and experimental models suggest that TG2 expression and activity in the tumour body and surrounding matrix generally decreases with tumour progression, favouring matrix destabilisation, but supporting angiogenesis and tumour invasion. In contrast, in the secondary metastatic tumour TG2 is often highly expressed whereby its potential roles in cell survival both at the intra- and extracellular level become important. In the following review the underlying molecular basis for the selection of these different phenotypes in tumour types and the anomaly for the requirement of TG2 is discussed in relation to the complex events of tumour progression. © 2007 Springer-Verlag.

KW - angiogenesis

KW - enzyme

KW - extracellular matrix

KW - tissue transglutaminase

KW - tumour growth

UR - http://www.scopus.com/inward/record.url?scp=34547697885&partnerID=8YFLogxK

UR - http://springerlink.metapress.com/content/8348068071lpj211/

U2 - 10.1007/s00726-007-0516-1

DO - 10.1007/s00726-007-0516-1

M3 - Article

VL - 33

SP - 373

EP - 384

JO - Amino Acids

JF - Amino Acids

SN - 0939-4451

IS - 2

ER -